Research News
A survey from the GW Cancer Center highlights the influence of supportive oncodermatology on patient quality of life.
There are dozens of questions surrounding COVID-19, and researchers at the George Washington University (GW) are intent on discovering the answers to them. Now, a coronavirus specimen bank will give investigators the tools they need to better understand this devastating virus.
The combination of photothermal and epigenetic therapies may help to maximize the therapeutic benefits for melanoma, and possibly other tumors, according to researchers from the George Washington University School of Medicine and Health Sciences (SMHS).
A new literature review from scientists at GW and NIST suggests that nutrition and diet have a profound impact on the microbial composition of the gut.
Researchers at GW published in the Journal of Clinical Oncology Clinical Cancer Informatics on the new knowledgebase OncoMX, which will improve the exploration and research of cancer biomarkers in the context of related evidence.
A research letter, published by members of SMHS and Children’s National Hospital in the Journal of the American Academy of Dermatology (JAAD), details results of a study that found a gap in access to treatment for severe acne among low-income communities.
A paper in npj (Nature Partner Journal) Genomic Medicine by Shawneequa Callier, JD, MA, of SMHS, examined the progress and challenges in increasing the amount of data on individuals with African ancestry in genomic research.
Earlier this year Sally Moody, PhD, chair of the Department of Anatomy and Cell Biology and professor of anatomy and cell biology at SMHS, earned the unique opportunity to take part in an international course in developmental biology held in Chile.
Physician-researchers at the George Washington University published a review suggesting that telehealth interventions are associated with improved obstetric outcomes.
Research from the George Washington University has found that apolipoprotein A-I binding protein restricts HIV-1 replication by targeting lipid rafts and reducing virus-cell fusion.